Stock Price
9.66
Daily Change
-0.17 -1.73%
Monthly
-38.98%
Yearly
-48.29%
Q2 Forecast
8.91

Adma Biologics reported $376K in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Novavax USD 303K 27K Dec/2021
Takeda JPY 87.87B 43.48B Dec/2025